ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

Mr. Thomas has been diagnosed with cancer

Patient Basic Information Patient: Mr. Thomas (Thomas Ramirez) Nationality: Germany Disease Diagnosis: Thyroid cancer Diagnostic Hospital: HQ 0 treatment program: Immunotherapy + Targeted Treatment Accommodation: 103 days Treatment cost: approximately 104,287 yuan Treatment effect: partial relief Following the arrival of the patient, for the first time, the International Medical Service Team arranged multidisciplinary MDT clinics for patients, developed individualized clinical pathways based on the patient's examination reports and physical condition, and provided translation, accompaniment and on-site services throughout the treatment process. The Therapy Team employs a comprehensive set of immunotherapy + targeted therapies, during which the medical team closely monitors the patient's indicators, dynamic adjustment programs.

After 103 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas and successfully reached the standard of discharge. The patient's treatment resulted in a partial relief. At the time of discharge, the medical team developed a detailed return follow-up and rehabilitation plan for the patient, and continued to monitor the recovery through a remote follow-up system.

'Mr. Liu Thomas criticizes the case as a typical case of cross-border suspected seriousness clinical cases. Liu4 is based on a multidisciplinary collaborative mechanism that develops immunotherapy + targeted treatment for thyroid cancer, reflecting the comprehensive strength of Chinese hospitals in the field of suspected disease clinics, and a summary of how international medical services are regulated.

(Figure from Liu5 official news reports and medical scenarios)

德国,甲状腺癌,福建医科大学附属协和医院,国际医疗,来华就医,中国医疗